Skip to main content
Premium Trial:

Request an Annual Quote

ExonHit Gets $553K Grant for Participation in RESPONSIFY Project

NEW YORK (GenomeWeb News) – ExonHit today said that it will receive a €418,000 ($553,000) grant from the European Union for its participation in the recently announced RESPONSIFY consortium.

The Paris-based firm said that it will provide its Genome Wide SpliceArray platform for analysis of patient transcriptomic profiles. The company added that it will be in charge of filing for IP protection for relevant molecular signatures and associated tests and ensuring CE marking and commercialization of predictive tests identified on the platform.

The RESPONSIFY consortium was recently launched with the aim of developing tests to indicate how therapies will affect individual patients and enable doctors to make better decisions about whether to use neoadjuvant therapies or provide treatments after surgery. The partners intend to identify predictive biomarkers for response to two common chemotherapeutic treatments for breast cancer, Herceptin (trastuzumab) and Avastin (bevacizumab).

The three-year project will include partners in Belgium, France, Germany, Sweden, Switzerland, and the UK, and is being funded with approximately €6 million under the EU's 7th Framework Programme for Research and Technological Development.

"This grant, which covers more than 70 percent of our costs in this project, enables us to add predictive tests in a key indication to our existing development portfolio," Loic Maurel, president of Exonhit's management board, said in a statement.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.